A naukri.com initiative
Bioengineer
1w
144
Image Credit: Bioengineer
CoQ Imbalance Triggers Reverse Electron Transport
- Groundbreaking research reveals how obesity disrupts liver metabolism by skewing the Coenzyme Q (CoQ) balance, leading to reverse electron transport (RET) and excessive mitochondrial reactive oxygen species (mROS) production.
- Molecular insights show that CoQ imbalance in obesity impairs hepatic CoQ biosynthesis, increasing the CoQH2/CoQ ratio and driving pathological mROS generation at complex I of the electron transport chain.
- Reverse electron transport, a bioenergetic process where electrons flow backward through complex I, is identified as a key driver of mROS overproduction in metabolic disease.
- Targeted inhibition of RET is shown to alleviate metabolic abnormalities, indicating a potential therapeutic strategy for restoring mitochondrial function in obese states.
- Human liver biopsies from obese patients confirm the CoQ imbalance-induced RET and mROS elevation, suggesting CoQ-related interventions may mitigate metabolic disturbances in clinical settings.
- The study fills a crucial gap in understanding mitochondrial bioenergetics by elucidating how CoQ imbalance influences pathological mROS production through RET, offering insights for disease-specific interventions.
- Fine-tuning CoQ redox ratios modulates RET magnitude and ROS production, highlighting a novel avenue for mitochondrial regulation and potential therapeutic interventions across various disorders.
- This research shifts the focus from broad antioxidant approaches to targeted strategies based on precise CoQ redox profiling, offering a promising path for correcting metabolic imbalances in diseases.
- CoQ imbalance and RET-driven mROS generation not only impact liver metabolism in obesity but also hold implications for a range of disorders, emphasizing the significance of mitochondria-focused therapies.
- By revealing the link between CoQ dynamics, RET, and mROS in metabolic dysfunction, this study paves the way for innovative treatments that restore cellular health and address the rising burden of metabolic diseases globally.
Read Full Article
8 Likes
For uninterrupted reading, download the app